COBLL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Due to the effects of Cobll1 on drug sensitivity in CML, we further validated the function of PACSIN2 on nilotinib resistance by evaluating the apoptotic index using fluorescence‐activated cell sorting (FACS) analysis (Figure S3).